✦ LIBER ✦

Randomised Trial of Two Different Daily Doses of Interferon-α versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C

✍ Scribed by Prof. G. Montalto, S. Tripi, O. Vuturo, G. Di Gaetano, M. Soresi, A. Spadaro, A. Aiello, M. Russello, R. Benigno, R. Siciliano

Book ID: 119929773
Publisher: Springer International Publishing AG
Year: 2002
Tongue: English
Weight: 140 KB
Volume: 22
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200222090-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: pre-dosing wi

Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1

✍ M. Palmer; R. Rubin; V. Rustgi; Taribavirin Viral Kinetic Study Group 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Correspondence: Treatment of chronic hep

Correspondence: Treatment of chronic hepatitis C in naive patients with high-dose interferon-α2a induction therapy and two different ribavirin doses

✍ H.G. Hass; C. Kreysel; O. Nehls; M. Gregor; S. Kaiser 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Treatment of chronic hepatitis C with pe

Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India

✍ Sood, Ajit; Midha, Vandana; Goyal, Omesh; Hissar, Syed; Sharma, Suresh Kumar; Kh 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 285 KB

Treatment of hepatitis C with daily indu

Treatment of hepatitis C with daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy in patients who are treatment naïve or have previously failed an interferon based therapy

✍ Lawitz, Eric J.; Kadakia, Shailesh C.; Cantu, Norma; Nader, Pierre; Cox, James; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Clinical trial: a randomized trial of pe

Clinical trial: a randomized trial of pegylated-interferon-α-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

✍ P. LANGLET; F. D’HEYGERE; J. HENRION; M. ADLER; J. DELWAIDE; H. VAN VLIERBERGHE; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Impact of disease severity on outcome of

Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C

✍ Johan Westin; Kristoffer Hellstrand; Åsa Alsiö; Magdalena Ydreborg; Carlo Ferrar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

The results encourage a new HDV classification in which the Deltavirus genus consists of 8 major clades, 5 of them being present in Africa (i.e., clade 1, 5, 6, 7, and 8). 7 Interestingly, clade 5 isolates represent approximately 20% of HDV RNA-positive samples, which is stable for the time period i